En

DOÇ.DR. ŞERİF ŞENTÜRK İZMİR ULUSLARARASI BİYOTIP VE GENOM ENSTİTÜSÜ GENOM BİLİMLERİ VE MOLEKÜLER BİYOTEKNOLOJİ ANABİLİM DALI

  • Eğitim / Akademik Bilgisi
    Lisans  Boğaziçi Üniversitesi Fen - Edebiyat Fakültesi Moleküler Biyoloji ve Genetik  2003
    Doktora  İ. D. Bilkent Üniversitesi Enstitü Moleküler Biyoloji ve Genetik Dalı  2010
    Yardımcı Doçent  Dokuz Eylül Üniversitesi İzmir Uluslararası Biyotıp ve Genom Enstitüsü  2015
    Doçent  Üniversitelerarası Kurul Başkanlığı Moleküler Biyoloji ve Genetik  2017
  • NO AD YIL
    1  Thioredoxin interacting protein promotes invasion in hepatocellular carcinoma...  2018
    2  Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization...  2017
    3  TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functi...  2016
    4  A rapid and tunable method to temporally control Cas9 expression enables the identification of essen...  2015
    5  MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppressio...  2015
    6  p53psi is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like ...  2014
    7  Imetelstat (a telomerase antagonist) exerts off target effects on the cytoskeleton...  2013
    8  Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activa...  2011
    9  Dose- and time-dependent expression patterns of zebrafish orthologs of selected E2F target genes in ...  2011
    10  Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tu...  2010
    11  The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneity...  2010
    12  Senescence and immortality in hepatocellular carcinoma...  2009
    13  Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells...  2009
    14  Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells...  2006
  • NO AD TARİH
    1  Kanser Esansiyel Genlerin Tüm Genom CRISPR-Cas9 Taramalarla Araştırılması... 18/10/2018 - 21/10/2018
    2  AXL as a Potential Target in Liver Cancer... 05/09/2018 - 08/09/2018
    3  Engineering and Functional Validation of Clonal Cell Lines with Stable Cas9 Expression for Genome-Wi... 05/09/2018 - 08/09/2018
    4  The Role of Malt1 Paracaspase in Hepatocellular Carcinoma... 05/09/2018 - 08/09/2018
    5  Systematic Comparison of Constitutive Promoters in Chinese Hamster Ovary Cells... 05/09/2018 - 08/09/2018
    6  Investigation of the Cellular Mechanisms of TGF-beta-induced Senescence-Resistance in Hepatocellular... 05/09/2018 - 08/09/2018
    7  The New Frontier of Genome Engineering: The CRISPR-Cas9 System ... 24/05/2018 - 27/05/2018
    8  Genom Mühendisliği ve CRISPR-Cas Devrimi... 10/05/2018 - 13/05/2018
    9  Biomarkers and CRISPR... 10/05/2017 - 12/05/2017
    10  CRISPR-Cas9 İşlevsel Genomik Tarama ve Rekabet Tayini ile Kanser Esansiyel Genlerin Keşfi ve İn ... 10/02/2017 - 12/02/2017
    11  Truncating Alleles in TP53 Produce Separation of Function Mutants That Actively Promote Tumorigenesi... 01/06/2016 - 05/06/2016
    12  In Vitro and In Vivo Characterization Of Cell Survival Genes Using Destabilized Cas9... 04/05/2016 - 07/05/2016
    13  A rapid and tunable method to temporally control Cas9 expression enables the characterization of ess... 24/09/2015 - 27/09/2015
    14  Does Akt inactivation promote metastasis of PTEN mutant cancer?... 12/05/2015 - 16/05/2015
    15  Functional characterization of genomic abnormalities that cooperate with EGFR and K-Ras oncogenic mu... 11/05/2015 - 12/05/2015
    16  Myc drives Pten/p53-deficient proliferation and metastasis due to Il6-secretion and Akt-suppression ... 18/04/2015 - 22/04/2015
    17  p53psi is a neomorphic p53 isoform that reprograms cells towards the acquisition of metastatic featu... 14/08/2012 - 18/08/2012
    18  Substrate specifity of receptor tyrosine kinases is critical for selective signaling... 14/08/2012 - 18/08/2012
    19  SOCS2 leads to EGFR TKi resistance in lung cancer by activating IL-6 mediated signaling... 14/08/2012 - 18/08/2012
    20  The Effects of Telomerase Inhibitor GRN163L (Imetelstat) On Cell Cytoskeleton and Cell Cycle... 28/10/2009 - 31/10/2009
    21  Effect of Akt pathway inhibitors in HCC: a novel target for treatment... 03/09/2009 - 06/09/2009
    22  The Effects of Telomerase Inhibitor "GRN163L" on Different Cell Lines... 11/07/2009 - 16/07/2007
    23  Downregulation and the anti-growth effect of Zeb2 in hepatocellular carcinoma... 21/05/2009 - 24/05/2009
    24  TGF-beta induces senescence in epithelial-like hepatocellular carcinoma cells... 21/05/2009 - 24/05/2009
    25  Molecular Mechanisms of TGF-beta-induced senescence in hepatocellular carcinoma... 29/10/2008 - 01/11/2008
    26  SMAD interacting protein 1 (SIP-1) acts as a negative regulator of growth in hepatocellular carcinom... 05/10/2007 - 07/10/2007
    27  TGF-beta induces p53/Rb-independent, but oxidative stress-dependent cellular senescence in hepatocel... 05/10/2007 - 07/10/2007
    28  Senescence induction as a potential therapeutic strategy in hepatocellular carcinoma... 13/09/2007 - 16/09/2007
    29  Induction of senescence as a potential therapeutic strategy in hepatocellular carcinoma... 09/07/2007 - 10/07/2007
    30  Role of TGF-beta and ROS signaling pathways in hepatocellular senescence... 24/03/2007 - 26/03/2007
    31  Role of SMAD interacting protein 1 in reprogramming of replicative senescence... 24/03/2007 - 26/03/2007
    32  Induction of replicative senescence in hepatocellular carcinoma cells... 24/06/2006 - 29/06/2006
    33  TGF-beta Signaling and Hepatocellular Senescence... 22/06/2006 - 24/06/2006
    34  Role of TGF-beta signaling in hepatocellular senescence... 22/06/2006 - 24/06/2006
    35  Characterization of TGF-beta-induced Early Senescence in Hepatocellular Carcinoma Cell Lines... 26/03/2006 - 31/03/2006
  • NO BÖLÜM ADI YIL
    1  Inducible CRISPR-Based Genome Editing for the Characterization of Cancer Genes Genome Editing and Engineering...  2018
  • NO AD TARIH
    1  Hepatoselüler Kanserde Tgf-ß Tarafından İndüklenen Senesans Karşıtı Direnç Mekanizmalarının Tüm Genom Transkriptom Analizi Ile Araştırılması...  6/2018 - /
    2  AXL'in KARACİĞER KANSERİN'DEKİ ROLÜ...  11/2017 - /
  • NO AD YIL
    1  Üstün Başarılı Genç Bilim İnsanı...  2017